Prelude Therapeutics Incorporated (PRLD) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Prelude Therapeutics Incorporated (PRLD) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

PRLD Income Statement

Prelude Therapeutics Incorporated (PRLD) annual income statement — 8-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	5.7M	4.58M	5.64M	6.5M	0	0	4M	3M	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	41%	116.67%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	391K	0	0	0	0	0	0	0	0	331K	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	8.54%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	5.7M	4.19M	5.64M	6.5M	0	0	4M	3M	0	0	-331K	0	0	0	0	0	0	0	0	0
Gross Margin %	100%	91.46%	100%	100%	-	-	100%	100%	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	41%	116.67%	-	-	1308.46%	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	21.16M	18.37M	22.99M	26.92M	32.19M	34.61M	37.83M	37.38M	37.16M	34.34M	37.05M	33.38M	32.4M	29.11M	33.38M	30.41M	29.46M	30.29M	33.01M	30.84M
OpEx % of Revenue	370.93%	401%	407.59%	414.12%	-	-	945.78%	1245.87%	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	5.03M	4.76M	5M	5.21M	6.41M	5.79M	6.21M	7.92M	7.66M	6.93M	6.72M	7.12M	7.43M	7.28M	7.52M	7.52M	8.15M	7.47M	7.83M	8.12M
SG&A % of Revenue	88.13%	104.04%	88.58%	80.15%	-	-	155.28%	263.97%	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	16.13M	13.6M	17.99M	21.71M	25.78M	28.82M	31.62M	29.46M	29.51M	27.41M	30.33M	26.26M	24.97M	21.83M	25.87M	22.89M	21.31M	22.82M	25.18M	22.72M
R&D % of Revenue	282.8%	296.97%	319.01%	333.97%	-	-	790.5%	981.9%	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	-1	0	0	-1	0	0	0	-1	0
Operating Income	-15.45M	-14.18M	-17.35M	-20.42M	-32.19M	-34.61M	-33.83M	-34.38M	-37.16M	-34.34M	-37.38M	-33.38M	-32.4M	-29.11M	-33.38M	-30.41M	-29.46M	-30.29M	-33.01M	-30.84M
Operating Margin %	-270.93%	-309.54%	-307.59%	-314.12%	-	-	-845.78%	-1145.87%	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	52%	59.03%	48.72%	40.6%	13.37%	-0.77%	9.49%	-2.97%	-14.71%	-17.96%	-11.96%	-9.8%	-9.97%	3.87%	-1.14%	1.39%	-5.51%	-37.88%	-69.75%	-69.95%
EBITDA	-15.1M	-13.79M	-16.93M	-19.99M	-31.76M	-34.17M	-33.34M	-33.97M	-36.71M	-33.92M	-37.05M	-33.11M	-32.12M	-28.84M	-33.02M	-30.07M	-29.14M	-29.98M	-32.72M	-30.57M
EBITDA Margin %	-264.74%	-301%	-300.18%	-307.58%	-	-	-833.55%	-1132.37%	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	52.45%	59.66%	49.22%	41.15%	13.49%	-0.75%	10%	-2.61%	-14.31%	-17.62%	-12.19%	-10.1%	-10.2%	3.82%	-0.93%	1.64%	-5.12%	-37.48%	-69.42%	-69.81%
D&A (Non-Cash Add-back)	353K	391K	418K	425K	433K	435K	489K	405K	452K	426K	331K	279K	281K	278K	362K	337K	318K	307K	290K	266K
EBIT	-13.92M	-10.38M	-16.46M	-19.73M	-31.23M	-32.09M	-28.73M	-32.27M	-34.74M	-31.43M	-33.08M	-33.38M	-32.4M	-29.11M	-33.38M	-30.41M	-29.46M	-30.29M	-33.01M	-30.84M
Net Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	1.53M	3.79M	891K	693K	963K	2.52M	5.1M	2.1M	2.42M	2.91M	4.3M	2.78M	1.97M	1.4M	4.74M	448K	2.09M	823K	168K	149K
Pretax Income	-13.92M	-10.38M	-16.46M	-19.73M	-31.23M	-32.09M	-28.73M	-32.27M	-34.74M	-31.43M	-33.08M	-30.61M	-30.43M	-27.72M	-28.64M	-29.96M	-27.37M	-29.46M	-32.84M	-30.69M
Pretax Margin %	-244.06%	-226.75%	-291.79%	-303.46%	-	-	-718.28%	-1075.7%	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-13.92M	-10.38M	-16.46M	-19.73M	-31.23M	-32.09M	-28.73M	-32.27M	-34.74M	-31.43M	-33.08M	-30.61M	-30.43M	-27.72M	-28.64M	-29.96M	-27.37M	-29.46M	-32.84M	-30.69M
Net Margin %	-244.06%	-226.75%	-291.79%	-303.46%	-	-	-718.28%	-1075.7%	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	55.43%	67.63%	42.72%	38.88%	10.1%	-2.08%	13.13%	-5.43%	-14.16%	-13.4%	-15.48%	-2.17%	-11.17%	5.93%	12.79%	2.38%	-1.89%	-38.33%	-70.61%	-83.1%
Net Income (Continuing)	-13.92M	-10.38M	-16.46M	-19.73M	-31.23M	-32.09M	-28.73M	-32.27M	-34.74M	-31.43M	-33.08M	-30.61M	-30.43M	-27.72M	-28.64M	-29.96M	-27.37M	-29.46M	-32.84M	-30.69M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.14	-0.13	-0.26	-0.26	-0.41	-0.42	-0.38	-0.43	-0.46	-0.42	-0.48	-0.45	-0.54	-0.55	-0.44	-0.62	-0.53	-0.61	-0.71	-0.66
EPS Growth %	65.85%	69.05%	31.58%	39.53%	10.87%	0%	20.83%	4.44%	14.81%	23.64%	-9.09%	27.42%	-1.89%	9.84%	38.03%	6.06%	8.62%	-29.79%	-39.22%	-50%
EPS (Basic)	-0.14	-0.13	-0.26	-0.26	-0.41	-0.42	-0.38	-0.43	-0.46	-0.42	-0.48	-0.45	-0.54	-0.55	-0.44	-0.62	-0.53	-0.61	-0.71	-0.66
Diluted Shares Outstanding	98.39M	82.52M	62.95M	76.13M	75.99M	75.99M	75.9M	75.86M	75.76M	75.74M	69.59M	67.64M	56.24M	47.74M	47.9M	47.45M	47.28M	47.07M	46.33M	46.33M
Basic Shares Outstanding	98.39M	82.52M	62.95M	76.13M	75.99M	75.99M	75.9M	75.86M	75.76M	75.74M	69.59M	67.64M	56.24M	47.74M	47.9M	47.45M	47.28M	47.07M	46.33M	46.33M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-